Overview

Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury

Status:
TERMINATED
Trial end date:
2025-07-21
Target enrollment:
Participant gender:
Summary
This study seeks to measure changes in cognition through verbal and visual test procedures and changes in biomarkers of Traumatic Brain Injury and inflammatory and metabolic parameters.
Phase:
PHASE2
Details
Lead Sponsor:
Neurological Associates of West Los Angeles
Collaborator:
BioVie Inc.